Oncology

Latest News

FDA approval-Olivier Le Moal-stock.adobe.com.jpeg
Mitomycin Intravesical Solution Gains FDA Approval for Recurrent Low-Grade NMIBC

June 12th 2025

The FDA approved mitomycin intravesical solution (Zusduri) for patients with recurrent low-grade intermediate risk non–muscle-invasive bladder cancer (NMIBC).

AJMC
Utilization and Costs Among Oncologists Participating in a Private Insurance Shared Savings Model

June 11th 2025

The new report suggests the C5a-C5aRq axis might be a useful target in combination with existing therapies for cutaneous squamous cell carcinoma. | Image credit: vladimircaribb - stock.adobe.com
C5aR1 Flagged as Biomarker in Cutaneous Squamous Cell Carcinoma

June 7th 2025

The study identified several molecular markers related to SCLC prognosis by integrating somatic mutation profiles, mRNA transcriptome data, and clinical information. | Image credit: vitstudio - stock.adobe.com
Novel Biomarkers May Inform Prognosis in SCLC

June 6th 2025

Structured exercise programs should be a part of the standard of care for colon cancer following adjuvant chemotherapy, authors of the COMMANDS study recommended. | Image credit: Drazen - stock.adobe.com
Structured Exercise Program Improves Outcomes, Quality of Life in Colon Cancer

June 6th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Are Patients Aware of Site of Care Differentials?
December 30th 2015

Are Patients Aware of Site of Care Differentials?

Disparity in Site of Care Costs and Patient Burden
December 30th 2015

Disparity in Site of Care Costs and Patient Burden

The Path to Site Neutrality
December 30th 2015

The Path to Site Neutrality

Performance-Based Contracting in Oncology
December 30th 2015

Performance-Based Contracting in Oncology

Can Indication-Based Pricing Be a Reality?
December 30th 2015

Can Indication-Based Pricing Be a Reality?

Oral Parity Laws and Patient Cost Sharing
December 30th 2015

Oral Parity Laws and Patient Cost Sharing

Drug Prices and Patient Burden in Oncology
December 30th 2015

Drug Prices and Patient Burden in Oncology

Bundled Payments in Oncology: What Do Payers Think?
December 30th 2015

Bundled Payments in Oncology: What Do Payers Think?

Implications of Bundled Payments in Oncology
December 30th 2015

Implications of Bundled Payments in Oncology

What Are the Constructs of Value-Based Care?
December 30th 2015

What Are the Constructs of Value-Based Care?

Can Academic Innovation in LDTs Be Halted?
December 30th 2015

Can Academic Innovation in LDTs Be Halted?

LDTs and the Political Wheelhouse
December 30th 2015

LDTs and the Political Wheelhouse

Justifying the Need for FDA Regulation of LDTs
December 30th 2015

Justifying the Need for FDA Regulation of LDTs

Payer and Consumer Response to FDA Regulation of LDTs
December 30th 2015

Payer and Consumer Response to FDA Regulation of LDTs

What Are LDTs and How Are They Regulated?
December 30th 2015

What Are LDTs and How Are They Regulated?

Introduction
December 30th 2015

Introduction

Site Logo
December 30th 2015

Physicians Discover Palbociclib Effective in Cancers Beyond Those of the Breast

Surabhi Dangi-Garimella, PhD
A literature review by researchers at the Abramson Cancer Center has identified a potential use of the cell cycle inhibitor palbociclib in a variety of cancers.
Site Logo
December 30th 2015

Most-Read Articles From AJMC's Conference Coverage in 2015

Surabhi Dangi-Garimella, PhD
Studies that provided updates on new drug trials, sessions on value-based care, and the cost of healthcare, were most popular among readers of The American Journal of Managed Care.
Site Logo
December 29th 2015

Using Technology to Bring Palliative Care to the Patient's Doorstep

Surabhi Dangi-Garimella, PhD
After having launched a palliative care program in 2014, Cambia Health Solutions is now looking for ways to improve patient access to these tools that can improve a patient's quality of life.
Site Logo
December 29th 2015

Cost, Value of Cancer Drugs Take Center Stage in Current Issue of AJMC's Evidence-Based Oncology

One of the biggest stories of 2015 has been the cost of cancer drugs, which create vexing questions for payers and policymakers, as well as doctors and families. The tough choices being made today are the theme of the latest special issue of Evidence-Based Oncology, a publication of The American Journal of Managed Care.
Site Logo
December 28th 2015

Improving Cancer Trial Participation via Web-Based Interventions

Surabhi Dangi-Garimella, PhD
Patient awareness and educational support can improve their attitude as well as prepare them to make better informed decisions on clinical trial participation, a new study has found.
Site Logo
December 28th 2015

Report: Shkreli Arrest Prompts Cancer Center to Stop Trial

Mary K. Caffrey
Moffitt Cancer Center said there's nothing wrong with the drug, but a spokesman said the trial is halted for now pending the outcome of the investigation.
Site Logo
December 28th 2015

Cancer's Toll Beyond the Disease: Medical Costs and Productivity

Surabhi Dangi-Garimella, PhD
A new study published by the American Cancer Society found that younger colorectal cancer survivors end up spending over $8500 annually in medical expenses and they also experience significantly greater loss of productivity compared with individuals without cancer.
This Week in Managed Care: December 26, 2015
December 26th 2015

This Week in Managed Care: December 26, 2015

This week The American Journal of Managed Care offers a special episode of highlights from the American Society of Hematology's annual meeting, including sessions on newly approved treatments, how the move to pay-for-performance affects hematologists, and the increasing role of patient-reported outcomes.
Site Logo
December 25th 2015

Most-Viewed Videos from AJMC for the Year 2015

Surabhi Dangi-Garimella, PhD
Top 10 videos from The American Journal of Managed Care's Summit and Insight programs.
Site Logo
December 23rd 2015

Rivaroxaban Safe and Effective in Cancer Patients With Thrombosis

Laura Joszt, MA
Although rivaroxaban was approved by the FDA in 2012, there has remained a knowledge gap about how it works with cancer patients. A recent study found that the therapy is safe and effective when used among patients with cancer.
Site Logo
December 22nd 2015

OB-GYN Groups Say Insurers' Genetic Testing Rules Limit Access to Care

Mary K. Caffrey
The statement from the obstetricians and gynecologists said that there aren't enough certified genetic counselors to meet demand. In a statement, the groups said this will limit access to care if patients must wait for assistance before ordering tests.
Site Logo
December 22nd 2015

Top 10 Articles from Evidence-Based Oncology for the Year 2015

Surabhi Dangi-Garimella, PhD
The most read articles in The American Journal of Managed Care's Evidence-Based Oncology ranged from personal narratives to healthcare policy issues that impact the broader population.
This Week in Managed Care: December 19, 2015
December 19th 2015

This Week in Managed Care: December 19, 2015

This week in managed care, Martin Shkreli, CEO of Turing Pharmaceuticals was arrested on charges of fraud; new research find that drug costs continue to take up a larger share of healthcare spending; and 3 healthcare experts take a look at how to fix the 340B drug pricing program.
Site Logo
December 18th 2015

Merck's Pembrolizumab Receives Approval for Expanded Indications

AJMC Staff
Pembrolizumab has been approved as first-line treatment for patients with unresectable or metastatic melanoma.
<1
...
113114115116117118119120121
...
186>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo